Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Tax Rate (QoQ) (2014 - 2026)

Analysis

Innoviva (INVA) Tax Rate (QoQ) (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 231.00
Sep 30, 2025 655.00
Jun 30, 2025 3,300.00
Sep 30, 2024 6,418.00
Jun 30, 2024 -735.00
Sep 30, 2023 -6,688.00
Jun 30, 2023 6,264.00
Sep 30, 2022 2,234.00
Jun 30, 2022 -1,982.00
Sep 30, 2021 -173.00
Jun 30, 2021 335.00
Mar 31, 2021 -1,747.00
Dec 31, 2020 1,509.00
Sep 30, 2020 78.00
Jun 30, 2020 6.00
Mar 31, 2020 -86.00
Dec 31, 2019 -75.00
Sep 30, 2019 -7.00
Jun 30, 2019 93.00
Mar 31, 2019 28,560.00